TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5751$ +0.9% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Balance Sheet

Humacyte Inc (HUMA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 116 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
169 107 287 204 128 138 116
95 41 229 154 83 48 68
94 40 218 150 80 45 50
94 40 226 152 80 45 50
0.6 0.1 0.2 0.0 0.0 0.0 0.4
0.0 0.0 0.0 0.0 0.0 14
74 65 35 30
36 36 164 87 115 191 113
11 11 11 20 18 20 18
3.1 4.2 2.0 11 2.6 2.9 2.4
3.3 2.3 2.1 1.6 6.5 4.5 5.4
0.8 27 20 39 35
132 71 122 117 14 -53 3.1
-322 -388 -415 -427 -537 -686 -727
103 12 40 103 103 118 158

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?